Wanbury's Q1 FY 2025-26 Quarter Results

Result Summary

• Wanbury Ltd reported a 16.5% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 23.8%.
• Its expenses for the quarter were up by 13.6% QoQ and 14.4% YoY.
• The net profit decreased 59.9% QoQ and increased 1197.1% YoY.
• The earnings per share (EPS) of Wanbury Ltd stood at 4 during Q1 FY 2025-26.

Financial Statments for Q1 FY 2025-26

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Wanbury Ltd operates within the pharmaceutical industry, primarily focusing on the production and sale of pharmaceutical products. The company is known for its active pharmaceutical ingredients (APIs) and formulations. As a pharmaceutical company, Wanbury is involved in the development, manufacturing, and marketing of a wide range of pharmaceutical solutions. Recent major developments specifically related to Wanbury Ltd are not available in the provided data. However, as a company in the pharmaceutical sector, it typically engages in activities such as research and development, regulatory compliance, and potential expansion into new markets or partnerships.

Revenue

In Q1FY26, Wanbury Ltd reported a total income of ₹163.53 crores. This represents a 16.5% increase quarter-over-quarter (QoQ) from ₹140.33 crores in Q4FY25 and a 23.8% increase year-over-year (YoY) from ₹132.05 crores in Q1FY25. The upward trend in revenue over both the quarterly and annual comparisons indicates an overall increase in income generation for the company. The consistent growth in total income suggests enhanced performance in the company's revenue-generating activities during this period.

Profitability

Wanbury Ltd's profitability, as measured by profit before tax (PBT), stood at ₹13.61 crores for Q1FY26. This is a significant decrease of 59.9% QoQ from ₹33.91 crores in Q4FY25. However, when compared to Q1FY25, there is a notable increase of 1208.7% from ₹1.04 crores. The profit after tax (PAT) for Q1FY26 was ₹13.49 crores, reflecting a similar QoQ decrease of 59.9% from ₹33.63 crores in Q4FY25, but showing a substantial YoY increase of 1197.1% from ₹1.04 crores. The earnings per share (EPS) for Q1FY26 was ₹4.00, which decreased by 60.4% QoQ from ₹10.10 in Q4FY25, yet increased by 1233.3% YoY from ₹0.30 in Q1FY25. These figures highlight the fluctuations in the company's profitability over the periods analyzed.

Operating Metrics

In the first quarter of fiscal year 2026, Wanbury Ltd reported total expenses of ₹149.92 crores, which marks a 13.6% QoQ increase from ₹131.98 crores in the previous quarter, Q4FY25. Compared to the same quarter of the previous year, Q1FY25, expenses increased by 14.4% from ₹131.01 crores. The tax expense for Q1FY26 was ₹0.12 crores, showing a 55.6% decrease from ₹0.27 crores in Q4FY25, with no comparable tax expense in Q1FY25. These operating metrics provide an insight into the company's cost management and tax obligations during the quarter.